See also: Tuberculosis and HIV for information about the TB and HIV together

Resources from the Centers for Disease Control and Prevention

For the General Public and Employers:

• Tuberculosis – General Information (fact sheet)
• Questions and Answers About TB (booklet)
• The Difference Between Latent TB Infection and TB Disease (fact sheet)
• Get the Facts About TB Disease (pamphlet)
• What You Need to Know about TB Infection (pamphlet)
• Tuberculosis Information for Employers in Non-Healthcare Settings (Fact sheet)

For Healthcare Providers:

• TB 101 for Healthcare Workers
• Core Curriculum on Tuberculosis
• Self-Study Modules on Tuberculosis
• TB Guidelines
• State TB Control Offices

Data and Statistics:

• Data and Statistics Overview
• Trends in Tuberculosis (fact sheet)
• Reported Tuberculosis in the United States (report)
• Tuberculosis in the United States (slide set)

Selected Recent Articles on Tuberculosis

•  Global Fund Raises $12.9B to Fight AIDS, Tuberculosis and Malaria.  (September 2016, Poz); related coverage from Science Speaks Blog
• U.S. Pledges Up to $4.3B to the Global Fund Through 2019.  (September 2016, Poz)
• Updated TB clinical practice guidelines advocate early therapy, case management.  (August 2016, Healio)
• Daily TB Treatment Better Than Intermittent.  (July 2016, MedPage Today)
• Community systems strengthening needed to end HIV, TB.  (July 2016, Science Speaks Blog)
• Disproportionate burden of HIV, hepatitis, TB among prisoners driven by IDUs, insufficient care.  (July 2016, Healio)
• Shortened regimen for MDR-TB shows good results for children.  (July 2016, AIDSmap)
• TB preconference highlights response stymied by neglect of patient needs and research funding deficits.  (July 2016, Science Speaks Blog)
• TB vaccine development in the 21st century takes new approaches.  (July 2016, Science Speaks Blog)
• TB2016 demands a global commitment to end TB.  (July 2016, AIDSmap)
• The War on Drugs Fuels the Spread of HIV, Hepatitis C and Tuberculosis.  (July 2016, Poz)
• Multi-country survey sheds light on drug-resistant tuberculosis treatment needs.  (July 2016, Science Speaks Blog)
• Case Western researchers receive grant to examine HIV, TB relationship.  (July 2016, Healio)
• “Test and treat” is the ideal – but in TB and other illnesses, “guess and treat” is the more common reality.  (June 2016, Science Speaks Blog)
• Senate agrees on global health funding, small boost for TB.  (June 2016, Science Speaks Blog)
• TB gets time and targets, as leaders weigh impacts of No. 1 killer.  (June 2016, Science Speaks Blog)
• Wanted: Continued development of TB diagnostics to reduce antimicrobial resistance.  (June 2016, Science Speaks Blog)
• Addressing development of tuberculosis diagnostics and drugs is critical to global antimicrobial resistance response, review finds.  (May 2016, Science Speaks Blog)
• Health workers face tuberculosis risks up to three times those of general population, while infection control, worker protections lag. (April 2016, Science Speaks Blog)
• As U.S. sees first rise in TB cases since early ’90s, World TB Day offers forum to count costs of missed opportunities.  (March 2016, Science Speaks Blog)
• Access to medicine, diagnostics and human rights… We’re reading how to fight TB.  (March 2016, Science Speaks Blog)
• Battling TB and other outbreaks “staff, stuff, space, and systems” still lacking.  (March 2016, Science Speaks Blog)
• Scientists find way to identify people at risk for active tuberculosis disease.  (March 2016, Science Speaks Blog)
• World TB Day 2016: CDC’s Shannon Hader on leadership against an epidemic.  (March 2016, Science Speaks Blog)
• Urine-based TB test lowers mortality. (March 2016, Healio)
• With TB now No. 1 global infectious disease killer, USAID justifies cuts to global TB funding. (March 2016, Science Speaks Blog)
• Acceptability of large-scale household-based TB screening: HPTN 071 (PopART) (CROI abstract); related coverage by AIDSmap and Healio.
• Direct transmission seems to drive XDR TB (MedPage Today); related coverage by AIDSmap and Healio.
• Empirical TB treatment comes up short again. (February 2016, AIDSmap); related coverage from Healio; abstract from 2016 Retrovirus Conference.
• White House slashes TB funding less than two months after launching National Plan to Combat MDR-TB. (February 2016, Science Speaks Blog)
• TB: With a plan on the table, an outbreak at home, U.S. Senators, UN Envoy urge White House to fund tuberculosis programs.  (January 2016, Science Speaks Blog)
• MDR-TB treatment: Six drugs better than five.  (January 2016, AIDSmap)
• USAID announces new partnerships to combat MDR-TB at White House plan launch. (January 2016, TheBodyPro)
• MDR-TB national action plan raises questions on targets and funding.  (January 2016, Science Speaks Blog)
• LAM point-of-care TB testing reduces mortality in people with HIV/TB co-infection in hospital. (January 2016, AIDSmap)
• One in eight children with confirmed TB have drug-resistant TB in Cape Town. (January 2016, AIDSmap)
• Global Health 2015: Top 10 stories in HIV, TB and more.  (December 2015, Science Speaks Blog)
• Community care workers boost TB case finding among hard-to-reach adults.  (December 2015, AIDSmap)
• White House releases plan to combat MDR-TB at home and around the world.  (December 2015, Science Speaks Blog)
• Obama Administration Releases National Action Plan for Combating Multidrug-Resistant Tuberculosis.  (December 2015, U.S. White House)
• The National Action Plan for Combating Multidrug-Resistant Tuberculosis. (December 2015, U.S. White House)
• Most important part of tuberculosis treatment is social support, patients say.  (December 2015, Science Speaks Blog)
• Global HIV, tuberculosis programs flat funded in FY 2016 spending bill, yet again.  (December 2015, Science Speaks Blog)
• Death during MDR-TB treatment more likely in people with HIV and underweight or most drug-resistant patients.  (December 2015, AIDSmap)
• 9-month MDR-TB regimen cures 82% in African study.  (December 2015, AIDSmap)
• Lancet TB series on local data, active case-finding, preventive treatment, community input and more.  (October 2015, Science Speaks Blog)
• Is plan for drug-resistant TB delayed amid cost concerns, while cost of delay goes unnoticed?  (October 2015, Science Speaks Blog)
• Newest MDR-TB drug prices could fall by up to 95% through generic production.  (October 2015, AIDSmap)
• TB death rate four times higher in Eastern Europe due to lack of HIV treatment after TB diagnosis.  (October 2015, AIDSmap)
• TB may be treatable with common glaucoma medication.  (July 2015, Medical News Today)
• Ambitious new U.S. plan may put hundreds of thousands on MDR-TB treatment.  (July 2015, Science Speaks Blog)
• Research reveals new insights into a key antibiotic target in the fight against TB.  (June 2015, Medical News Today)
• Multidrug-resistant TB appears less transmissible in households than drug-susceptible TB.  (June 2015, Medical News Today)
• Fighting tuberculosis using the body’s natural anti-microbial processes.  (June 2015, Medical News Today)
• Spinal tuberculosis may be treated surgically or with drugs.  (June 2015, Healio)
• Trial of all-oral XDR-TB treatment begins.  (May 2015, Healio)
• First all-oral XDR-TB drug regimen trial launches in South Africa.  (May 2015, Science Speaks Blog)
• High-dose rifampicin may shorten time to TB clearance.  (April 2015, AIDSmap)
• T-cell biomarkers distinguish active, latent M. tuberculosis infection.  (April 2015, Healio)
• To end TB, treat the missing millions.  (March 2015, Medical News Today)
• PaMZ shows promise to shorten TB therapy.  (March 2015, Healio)
• TB incidence in US declines 2.2%.  (March 2015, Healio)
• Decline in U.S. Tuberculosis Rates Slows: CDC.  (March 2015, WebMD.
• TB’s ability to evade immune system becomes clearer in large study.  (March 2015, Medical News Today)
• Clustered transmission responsible for majority of XDR-TB cases.  (February 2015, Healio)
• Drug-resistant TB may be treatable with new small molecule drug.  (February 2015, Medical News Today)
• High-dose rifampin reduced time to TB culture conversion.  (February 2015, Healio)
• TB drug candidate starts Phase 1 trial – first in six years.  (February 2015, Science Speaks Blog)
• PET scans can help select best TB drugs for trials.  (December 2014, Medical News Today)
• Increased expenditure on social security has benefits for TB control in the EU.  (October 2014, AIDSmap)
• Bedaquiline as part of tailored therapy for MDR- and XDR-TB achieves impressive culture conversion rates.  (October 2014, AIDSmap)
• WHO report: TB is more widespread than previously estimated.  (October 2014, Medical News Today)
• TB strain identification via ‘genetic barcode.’  (September 2014, Medical News Today)
• Use of drug susceptibility testing to select therapy improves treatment outcomes inpatients with MDR- and XDR-TB.  (August 2014, AIDSmap)
• Global burden of HIV, malaria, and TB has decreased since ‘the Millennium Declaration.’  (July 2014, Medical News Today)
• GeneXpert with clinic-based care reduced time to treatment for MDR TB patients in Khayelitsha, South Africa.  (July 2014, Science Speaks Blog)
• PaMZ TB drug regimen: Cheaper, simpler, safer, and with effectiveness “significantly greater” than standard regimen, researchers say.  (July 2014, Science Speaks Blog)
• Investigational TB vaccine to be tested.  (March 2014, Healio)
• Rifampicin dose can be increased safely in TB treatment, may shorten duration.  (November 2013, AIDSmap)
• Another negative result in the quest for a shorter TB treatment course.  (November 2013, AIDSmap)
• Eastern Europe facing quadruple epidemic while governments do nothing, warns UN Special Envoy.  (October 2013, AIDSmap)
• UK patients with MDR-TB have good outcomes but a quarter not receiving the recommended duration of therapy.  (October 2013, AIDSmap)